Research Study Comparing a New Medicine " Fast-acting Insulin Aspart " to Another Already Available Medicine " NovoRapid " / " NovoLog " in People With Type 2 Diabetes
Conditions: Diabetes; Diabetes Mellitus, Type 2 Interventions: Drug: Faster-acting insulin aspart; Drug: Insulin aspart; Drug: Insulin degludec; Drug: Metformin Sponsor: Novo Nordisk A/S Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Insulin | Metformin | NovoLog | Study